Evommune Inc.
EVMN | NYSE
$6.22
-$0.51 (-7.58%)
Nov 2, 2026, 12:18 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | -94.67M | -75.99M | -68.87M | -61.32M | -48.85M | -62.67M | -50.89M | -30.17M | -2.78M |
Depreciation & Amortization | 1.54M | 1.36M | 1.39M | 1.42M | 1.11M | 1.06M | 956K | 596K | 271K |
Stock-Based Compensation | 4.6M | n/a | n/a | 494K | 494K | 494K | 494K | n/a | n/a |
Other Working Capital | 7.83M | 899K | -3.28M | -8.12M | -10.69M | -8.54M | -746K | 302K | -1.47M |
Other Non-Cash Items | 5.57M | -2.42M | -4.84M | -8.9M | -8.95M | -264K | -669K | -223K | -161K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.81M | -3M | -4.12M | -9.95M | -12.43M | 10.34M | 18.14M | 16.34M | -2.16M |
Operating Cash Flow | -74.15M | -80.05M | -76.44M | -78.25M | -68.62M | -51.04M | -31.97M | -13.46M | -4.83M |
Capital Expenditures | -501K | -318K | -235K | -131K | n/a | -18K | -88K | -88K | -70K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -325.59M | -307.95M | -199.17M | -83.36M | -44.58M | -61.28M | -73.57M | -28.99M | -12.28M |
Sales Maturities Of Investments | 125.22M | 94.1M | 84.1M | 58M | 43M | 51.75M | 60.25M | 48.75M | 22M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -1 | -1 | -1 | n/a |
Investing Cash Flow | -200.87M | -214.17M | -115.31M | -25.49M | -1.58M | -9.55M | -13.41M | 19.68M | 9.65M |
Debt Repayment | -602K | -615K | -528K | -684K | -239K | -84K | -84K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -179K | -915K | -1.07M | 100K | -945K | -317K | -225K | -170K | -62K |
Financial Cash Flow | 274.22M | 338.03M | 220.76M | 113.62M | 113.89M | 49.44M | 49.53M | -168K | -60K |
Net Cash Flow | -2.01M | 42.61M | 44.06M | 24.93M | 59.95M | 3.81M | -1.89M | n/a | n/a |
Free Cash Flow | -74.65M | -80.36M | -76.68M | -78.39M | -68.62M | -51.06M | -32.06M | -13.54M | -4.9M |
Adj. Free Cash Flow | -79.25M | -80.36M | -76.68M | -78.88M | -69.11M | -51.55M | -32.55M | -13.54M | -4.9M |
Maintenance CapEx | -501K | -318K | -235K | -131K | -18K | -88K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -74.65M | -80.36M | -76.68M | -78.39M | -77.26M | -55.96M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove EVMN